Cannabis Science Inc.
Cannabis Science Inc.
Home
About Us
Corporate Overview
Mission Statement
Cannabis Science Team
Careers & Corporate Culture
iCannabinoid
Join Now!
R&D
The Science of Cannabinoids
CBIS Cannabinoid Research
Critical Ailments
COLLABORATIONS & PROJECTS
CBIS Medical Consortium
Global Economic Development
Pan African A & C University
African Economic Initiative
American States University
North American Economic Initiative
Dana-Farber
CFA
Stellenbosch University
CBIS Bottle It
Products & Pharmacies
Products
Order Online
Pharmacies
Investors
CBIS Current Share Structure
SEC Filings
Media
CBIS News Releases
CBIS In The News
CBIS Events
Contact
latest Articles
Cannabis Science Issues 2019 Guidance Report; Under SEC Sanctions the Company Goes Private as It Enters Into Step (2) of Its Growth Transition, Enabling Full Transparency and Revenue Growth
Cannabis Science Enters Transition Stage as Trading of the Company’s Shares is Halted; The Company Will Continue to Implement Its Growth Strategy and Resolve All Outstanding Fully Reporting Requirements
Cannabis Science Partners With CDN Firm NHS Industries to Launch the CBIS CDN Economic Development Plan; CBIS to Use Its Relations With the Harvard International Phytomedicines and Medical Cannabis Institute and Other Leading Institutions
Cannabis Science Prepares Announcements for Revenues and Corporate Growth; Finalizing New Asset Partnerships and Acquisitions Targeting Positive Cash Flow in Key Markets Globally
Cannabis Science Successfully Completes European Headquarters and Operations Move to The Netherlands and Completes Shut Down of All Cannabis Science Europe GmbH Germany Operations
CBIS LATEST NEWS.
Home
2016
2018
-
2017
-
2016
-
2015
-
2014
-
2013
-
2012
-
2011
-
2010
-
2009
Warning
: Creating default object from empty value in
/home/cannabisscience/public_html/plugins/system/t3/base-bs3/html/com_content/category/default_articles.php
on line
17
Title
Published Date
Cannabis Science Negotiates a Total 360,000 Sq. Ft. Licensed Cannabinoid Grow and Formulation Processing in Nevada, Including Facilities for Educational and Medical Clinic and Laboratory for Drug Development Programs Targeting Multiple Critical Ailments
24-03-16
Positive Cannabinoid Testing Data in California Prompts Cannabis Science Lab Expansions for IGXBio's GenePro FDA Investigational New Drug (IND) Number 015982 for Further Drug Development to Identify & Develop Agonist Cannabinoids for GenePro
16-03-16
Cannabis Science Moves Forward Clinical Drug Development With Confidence as GW Pharma Announces Positive Results With Its CBD-Based Epilepsy Formulation
14-03-16
Cannabis Science CEO Plans to Expand Share Gifts to ALL Shareholders up to March 31, 2016, Thus Including ALL Old & New Shareholders up to the New Cutoff Date; Issues Preliminary Instructions for Shareholders of Record Dates to Receive Gifted Shares
11-03-16
In an Unprecedented Move, Cannabis Science President & CEO, Mr. Raymond C. Dabney, to Gift His Personal Shares to Shareholders to Replace Both Previously Announced Dividends, to Personally Complete Promised Payouts
04-03-16
CBIS Set to Partner and Power the New iPhone APP, "The Joey Network", Just Released by Mieko Hester-Perez, SAB Member, Providing Patients and Families a Wealth of Autism Resources and Cannabis Treatment Options
01-03-16
Purple Haze Properties (PHP) & Cannabis Science (CBIS) Announce Successful Launch of Hendrix-Themed Cannabis Theraputic Products
24-02-16
Cannabis Science Targets Successful Autism Treatments and Brings Family Autism Advocate Mieko Hester-Perez on Its Scientific Advisory Board
09-02-16
CBIS & Purple Haze Properties Launch "Jimi's Meds" eCommerce Website Powered by Cannabis Science and Showcased This Weekend at the High Times Cannabis Cup in Southern California
28-01-16
Cannabis Science Announces Update on Issuance of Dividends
11-01-16
Start
Prev
1
2
3
4
5
6
7
Next
End